D007136Chemicals & DrugsD12.776.124.486.485D12.776.124.790.651D12.776.377.715.54823280.985362ImmunoglobulinsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28755067Borte M, Melamed IR, Pulka G, Pyringer B, Knutsen AP, Ochs HD, Kobayashi RH, Kobayashi AL, Gupta S, Strach M, Smits W, Pituch-Noworolska A, Moy JNJournal of clinical immunologyEfficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga?) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study. J Clin Immunol. 2017 Aug; 37(6):603-612.J Clin Immunol2017-07-29T00:00:002017Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga?) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study.true1ProfessorProfessortrue1ProfessorProfessorPsychiatryNadimHallabNadim Hallab41.87352120000000-87.66713820000000349072Hallab, NadimProfessorMarkPollackMark Pollack41.87724600000000-87.66843480000000349127Pollack, MarkProfessorJamesMoyJames Moy349570Moy, JamesAssociate ProfessorCosticaAlomanCostica Aloman349601Aloman, CosticaAssociate Professor5Associate Professor4Professor0.7473320.0053236223research area of0.7584340.01527931subject area fortrue1ProfessorProfessor32229747Samelko L, Petfield J, McAllister K, Hsu J, Hawkinson M, Jacobs JJ, Hallab NJClinical orthopaedics and related researchDo Battlefield Injury-acquired Indwelling Metal Fragments Induce Metal Immunogenicity? Clin Orthop Relat Res. 2020 04; 478(4):752-766.Clin Orthop Relat Res2020-04-01T00:00:002020Do Battlefield Injury-acquired Indwelling Metal Fragments Induce Metal Immunogenicity?26154922Larsen CP, Messias NC, Walker PD, Fidler ME, Cornell LD, Hernandez LH, Alexander MP, Sethi S, Nasr SHKidney internationalMembranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int. 2015 Oct; 88(4):867-73.Kidney Int2015-07-08T00:00:002015Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.26700965Stanca CM, Aloman C, Fiel MI, Raja K, Uskudar O, Florman S, Schiano TDClinical transplantationThe dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. Clin Transplant. 2016 Mar; 30(3):241-6.Clin Transplant2016-01-16T00:00:002016The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients.Internal MedicineOrthopedic SurgeryRush University, Rush Medical CollegeJoshuaJacobsJoshua J. Jacobs41.87352120000000-87.66713820000000349020Jacobs, Joshua0000-0003-3902-7334Professor34605781Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Hylander M?ller M, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy MCritical care medicineSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021 11 01; 49(11):e1063-e1143.Crit Care Med2021-11-01T00:00:002021Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.Internal Medicine, Division of Digestive Diseases and Nutritiontrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professor